QNTLO is a niche clinical biostatistics consultancy focused on early-phase (Phase I–II) trials and dose-selection decisions that set studies up for Phase III success. We keep the team intentionally small so every project gets senior attention, clear communication, and fast decisions.

We work to ISO 9001 principles and ICH/GCP expectations, with a lean, documented Quality Management System that governs how we plan, execute, review, and release every deliverable. Confidentiality, data protection (GDPR), and information security are built into our processes and tools.

QNTLO

Org chart

Teams

Offices